Advancing Therapeutic Developments Through Innovation Clusters

Time: 12:10 pm - 12:20 pm

Date: 1 May 2019

1-may-2019 12:10 1-may-2019 12:20 Europe/London Advancing Therapeutic Developments Through Innovation Clusters

CEAT – the Cluster for Epigenomic and Antibody-Drug Conjugate Therapeutics (CEAT) is an innovation model aimed at bringing together academic, clinical and industrial stakeholders to deliver advances in novel epigenetic drugs and Antibody Drug Conjugate (ADC) developments. This talk will outline the therapeutic areas and the development pipeline in CEAT.

Making Pharmaceuticals

Synopsis

CEAT – the Cluster for Epigenomic and Antibody-Drug Conjugate Therapeutics (CEAT) is an innovation model aimed at bringing together academic, clinical and industrial stakeholders to deliver advances in novel epigenetic drugs and Antibody Drug Conjugate (ADC) developments. This talk will outline the therapeutic areas and the development pipeline in CEAT.

Speakers

« Back